WHO ICTRP trial
Efficacy and safety of prolyl hydroxylase inhibitors on erythropoietin…
ChiCTR2000031645 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000031645 |
|---|---|
| Public title | Efficacy and safety of prolyl hydroxylase inhibitors on erythropoietin hypo-responsiveness in hemodialysis patients with renal anaemia: a prospective cohort study |
| Scientific title | Efficacy and safety of prolyl hydroxylase inhibitors on erythropoietin hypo-responsiveness in hemodialysis patients with renal anaemia: a prospective cohort study |
| Primary sponsor | Ya'an People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Renal anemia |
| Interventions | Case series:prolyl hydroxylase inhibitors |
| Registration date | Apr 6, 2020 |
| Target size | Case series:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: